• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; VELA INFRARENAL CUFF

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; VELA INFRARENAL CUFF Back to Search Results
Model Number A34-34/C80 V
Device Problems Detachment Of Device Component (1104); Migration or Expulsion of Device (1395); Stretched (1601)
Patient Problem Failure of Implant (1924)
Event Date 11/27/2017
Event Type  Injury  
Manufacturer Narrative
In addition to the confirmed type 3a endoleak and the secondary endovascular procedure on (b)(6) 2017 (reference 2031527-2017-00693), clinical also found a complete component separation; cuff migration (1.5 cm); main body buckling; 3b of the cuff and superior stent cage dilation (28%).Cumulative knowledge informed by past assessments of similar complaints was applied to a review of the available medical information.The most likely cause of the compromised stent integrity of the cuff (breached), and the main body (superior stent margin) was the use of the strata material in combination with a progressive loss of overlap, likely cause by an extreme aortic and an iliac tortuosity.The complete component separation resulted in a loss of seal.The resultant component remodeling likely caused the stent migration and near complete buckling of the main body stent.Intra-operatively, the buckling precluded the physician from performing a successful reline and an additional surgical femoral to femoral bypass (and an aui procedure) was needed to repair the system.The patient was discharged home in stable condition.A review of the manufacturing lot confirmed all devices met specifications prior to release.The devices remain implanted in the patient and were not returned and no evaluation was completed.These types of events will be monitored and trended as part of the quality system.
 
Event Description
The patient was initially implanted with a bifurcated stent and a suprarenal aortic extension.A routine follow up showed the patient had a type 3a endoleak.The physician elected to implant a non-endologix cook device to seal the endoleak.Patient was discharge home in stable condition.Upon clinical evaluation, patient was also noted for a complete component separation; a cuff migration and main body buckling; iiib of the cuff; and superior stent cage dilation.No further information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
VELA INFRARENAL CUFF
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
victor arellano
2 musick
irvine, CA 92618
9495984671
MDR Report Key7318135
MDR Text Key101652074
Report Number2031527-2018-00153
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009013545
UDI-Public(01)00818009013545(17)150213
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date02/13/2015
Device Model NumberA34-34/C80 V
Device Lot Number1164476014
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/27/2017
Initial Date FDA Received03/06/2018
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/11/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BIFURCATED STENT GRAFT, LOT 1101252-030
Patient Outcome(s) Required Intervention;
Patient Age72 YR
-
-